408 related articles for article (PubMed ID: 36831187)
21. Assessment of mitophagy in human iPSC-derived cardiomyocytes.
Yang M; Fu JD; Zou J; Sridharan D; Zhao MT; Singh H; Krigman J; Khan M; Xin G; Sun N
Autophagy; 2022 Oct; 18(10):2481-2494. PubMed ID: 35220905
[TBL] [Abstract][Full Text] [Related]
22. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
[TBL] [Abstract][Full Text] [Related]
23. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
24. Generation of a gene-corrected human induced pluripotent stem cell line derived from a patient with laterality defects and congenital heart anomalies with a c.455G > A alteration in DAND5.
Inácio JM; Almeida M; Cristo F; Belo JA
Stem Cell Res; 2020 Jan; 42():101677. PubMed ID: 31869685
[TBL] [Abstract][Full Text] [Related]
25. Role of Heme-Oxygenase-1 in Biology of Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells.
Jeż M; Martyniak A; Andrysiak K; Mucha O; Szade K; Kania A; Chrobok Ł; Palus-Chramiec K; Sanetra AM; Lewandowski MH; Pośpiech E; Stępniewski J; Dulak J
Cells; 2021 Mar; 10(3):. PubMed ID: 33804563
[TBL] [Abstract][Full Text] [Related]
26. Single-cell protein expression of hiPSC-derived cardiomyocytes using Single-Cell Westerns.
Jabart E; Molho J; Sin K; Stansfield B; Kazmouz SG; Ventro D; Gardner K; Wu JC; Churko JM
J Mol Cell Cardiol; 2020 Dec; 149():115-122. PubMed ID: 33010256
[TBL] [Abstract][Full Text] [Related]
27. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
28. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model.
Cumberland MJ; Euchner J; Azad AJ; T N Vo N; Kirchhof P; Holmes AP; Denning C; Gehmlich K
F1000Res; 2023; 12():1224. PubMed ID: 38298530
[TBL] [Abstract][Full Text] [Related]
29. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.
Wang L; Wada Y; Ballan N; Schmeckpeper J; Huang J; Rau CD; Wang Y; Gepstein L; Knollmann BC
J Mol Cell Cardiol; 2021 Dec; 161():130-138. PubMed ID: 34400182
[TBL] [Abstract][Full Text] [Related]
30. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
31. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
[TBL] [Abstract][Full Text] [Related]
32. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
[TBL] [Abstract][Full Text] [Related]
33. Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells.
Winbo A; Ramanan S; Eugster E; Jovinge S; Skinner JR; Montgomery JM
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H927-H937. PubMed ID: 32822546
[TBL] [Abstract][Full Text] [Related]
34. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.
Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW
J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713
[TBL] [Abstract][Full Text] [Related]
35. Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods.
Prajapati C; Ojala M; Lappi H; Aalto-Setälä K; Pekkanen-Mattila M
Stem Cell Res; 2021 Mar; 51():102176. PubMed ID: 33485184
[TBL] [Abstract][Full Text] [Related]
36. Elimination of residual undifferentiated induced pluripotent stem cells (iPSCs) using irradiation for safe clinical applications of iPSC-derived cardiomyocytes.
Takeda M; Ito E; Minami K; Harada A; Mochizuki-Oda N; Sawa Y; Miyagawa S
Biochem Biophys Res Commun; 2021 Oct; 574():91-96. PubMed ID: 34450429
[TBL] [Abstract][Full Text] [Related]
37. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.
Yamoah MA; Moshref M; Sharma J; Chen WC; Ledford HA; Lee JH; Chavez KS; Wang W; López JE; Lieu DK; Sirish P; Zhang XD
Int J Nanomedicine; 2018; 13():6073-6078. PubMed ID: 30323594
[TBL] [Abstract][Full Text] [Related]
38. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
39. Defective Biomechanics and Pharmacological Rescue of Human Cardiomyocytes with Filamin C Truncations.
Lazzarino M; Zanetti M; Chen SN; Gao S; Peña B; Lam CK; Wu JC; Taylor MRG; Mestroni L; Sbaizero O
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474188
[TBL] [Abstract][Full Text] [Related]
40. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
